- Official inclusion in Egypt's Ministry of Health UHI (Universal Health Insurance) system
- Overwhelming cost-saving benefits drive insurance approval
- Full-scale support for Cairo-based 'Vascular ART COE' led by leading Middle Eastern authority… nationwide expansion across Egypt

▲ Opening ceremony of the Vascular ART COE in Cairo, Egypt

ROKIT Healthcare (KOSDAQ 376900), a specialist in AI-driven hyper-personalized organ regeneration platforms, has officially secured Universal Health Insurance (UHI) coverage for its AI diabetic foot regeneration treatment platform in Egypt, a country with approximately 13 million diabetes patients.

This milestone is the culmination of two years of clinical trials and skin regeneration surgeries conducted on-site in Egypt. With this achievement, ROKIT Healthcare can now deliver innovative regenerative treatments at scale to patients within Egypt's national insurance framework. Furthermore, with the establishment of the UAE-based ROKIT MENA joint venture, the company is poised to capture explosive growth momentum in the North African and Middle Eastern (GCC) skin regenerative medicine markets.

Beyond Regenerative Technology: Becoming a National Standard of Care

The Egyptian government is currently undertaking a comprehensive overhaul of its healthcare system by establishing a Universal Health Insurance (UHI) framework as part of its national strategic initiative, Egypt Vision 2030. In Egypt, where diabetes prevalence is particularly high, diabetic complications such as diabetic foot ulcers impose enormous social costs and healthcare expenditures.

Against this backdrop, ROKIT Healthcare's national insurance approval is being hailed as a paradigm shift in Egypt's diabetic foot treatment. Moving away from the costly and inefficient conventional approaches—skin grafts, basic wound care, infection control, and ultimately amputation—ROKIT Healthcare's advanced AI-powered skin regeneration therapy, centered on limb preservation, has been officially recognized as a government-backed standard of care.

ROKIT Healthcare gained strong support from the local government and medical community by providing platform technology training at the Vascular ART COE, a medical hub based in Cairo. The center is spearheaded by Dr. Mahmoud Salah, president of the Middle Eastern Vascular Specialists Association and one of the region's foremost authorities. Dr. Salah's decade-long vision for a "one-stop diabetic foot medical center" has reportedly materialized through its partnership with ROKIT Healthcare's technology, culminating in the national insurance milestone.

The Overwhelming Efficiency of AI and 3D Bioprinting

Analysts note that technological efficiency played a significant role in the Egyptian Ministry of Health's decision to fast-track ROKIT Healthcare's platform into the national insurance system. The platform utilizes AI to precisely analyze patient wounds and 3D bioprinting to generate customized tissue regeneration patches on-site in real time.

This one-stop treatment approach aligns with Egypt's healthcare delivery reform, which emphasizes early screening at primary care facilities followed by intensive treatment at specialized centers. This is expected to maximize the efficiency of the local healthcare system and create an environment where more patients can receive regenerative treatment at an earlier stage.

Above all, the most compelling rationale for insurance inclusion was the platform's ability to dramatically reduce amputation rates while simultaneously lowering long-term hospitalization costs, significantly easing the fiscal burden on Egypt's national health insurance system.

Public Insurance Access: Not an Option, but a Necessity

Egypt, home to 13 million diabetes patients, is regarded as a "blue ocean for diabetic foot regenerative medicine," with an adult prevalence rate reaching 22.4%—making it one of the largest markets in the world.

A ROKIT Healthcare representative stated, "The moment advanced regenerative medicine technology crosses the threshold of national health insurance, the trajectory of market growth shifts to an entirely different dimension. This Egyptian national insurance approval will serve as a powerful signal flare, not only securing dominance in the North African medical hub but also heralding ROKIT Healthcare's formation of a global mega-trend extending across the entire GCC region."